nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—rheumatoid arthritis	0.4	1	CbGaD
Lornoxicam—PTGS2—Sulfasalazine—rheumatoid arthritis	0.107	0.193	CbGbCtD
Lornoxicam—PTGS2—Triamcinolone—rheumatoid arthritis	0.107	0.193	CbGbCtD
Lornoxicam—PTGS2—Betamethasone—rheumatoid arthritis	0.0914	0.166	CbGbCtD
Lornoxicam—PTGS1—Sulfasalazine—rheumatoid arthritis	0.09	0.163	CbGbCtD
Lornoxicam—CYP2C9—Leflunomide—rheumatoid arthritis	0.0586	0.106	CbGbCtD
Lornoxicam—PTGS2—Dexamethasone—rheumatoid arthritis	0.0532	0.0964	CbGbCtD
Lornoxicam—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0274	0.0497	CbGbCtD
Lornoxicam—CYP2C9—Dexamethasone—rheumatoid arthritis	0.0181	0.0328	CbGbCtD
Lornoxicam—Tenoxicam—PTGS2—rheumatoid arthritis	0.00115	0.347	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—rheumatoid arthritis	0.000816	0.247	CrCbGaD
Lornoxicam—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000782	0.159	CbGdCrCtD
Lornoxicam—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.00077	0.156	CbGdCrCtD
Lornoxicam—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.00077	0.156	CbGdCrCtD
Lornoxicam—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000752	0.153	CbGdCrCtD
Lornoxicam—Piroxicam—PTGS2—rheumatoid arthritis	0.000708	0.214	CrCbGaD
Lornoxicam—Piroxicam—ALB—rheumatoid arthritis	0.000631	0.191	CrCbGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNFSF13B—rheumatoid arthritis	0.000534	0.0134	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—rheumatoid arthritis	0.000532	0.0134	CbGpPWpGaD
Lornoxicam—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000472	0.0958	CbGdCrCtD
Lornoxicam—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000464	0.0943	CbGdCrCtD
Lornoxicam—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000464	0.0943	CbGdCrCtD
Lornoxicam—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000454	0.0921	CbGdCrCtD
Lornoxicam—PTGS1—Overview of nanoparticle effects—CRP—rheumatoid arthritis	0.000445	0.0112	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.000441	0.0111	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—PTK2—rheumatoid arthritis	0.00043	0.0108	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—FN1—rheumatoid arthritis	0.000411	0.0103	CbGpPWpGaD
Lornoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—rheumatoid arthritis	0.00041	0.0103	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—AHR—rheumatoid arthritis	0.000384	0.00964	CbGpPWpGaD
Lornoxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—rheumatoid arthritis	0.000381	0.00958	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	0.000369	0.00927	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—rheumatoid arthritis	0.000362	0.0091	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—CRP—rheumatoid arthritis	0.000353	0.00888	CbGpPWpGaD
Lornoxicam—PTGS2—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.00035	0.00879	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—rheumatoid arthritis	0.000344	0.00865	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—FN1—rheumatoid arthritis	0.000326	0.00819	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—ACAN—rheumatoid arthritis	0.000306	0.0077	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—rheumatoid arthritis	0.0003	0.00753	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—PTGS2—rheumatoid arthritis	0.000299	0.0075	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—rheumatoid arthritis	0.000296	0.00745	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—rheumatoid arthritis	0.000292	0.00733	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—CXCL8—rheumatoid arthritis	0.00029	0.00727	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—ALOX5—rheumatoid arthritis	0.00028	0.00704	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—rheumatoid arthritis	0.00028	0.00703	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—rheumatoid arthritis	0.000279	0.007	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—ZFP36—rheumatoid arthritis	0.000273	0.00686	CbGpPWpGaD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—rheumatoid arthritis	0.000271	0.00681	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—rheumatoid arthritis	0.000267	0.00671	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—rheumatoid arthritis	0.000249	0.00626	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—MPO—rheumatoid arthritis	0.000248	0.00624	CbGpPWpGaD
Lornoxicam—PTGS1—Eicosanoid Synthesis—PTGS2—rheumatoid arthritis	0.000248	0.00622	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MIF—rheumatoid arthritis	0.000241	0.00604	CbGpPWpGaD
Lornoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—rheumatoid arthritis	0.000236	0.00593	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SAA1—rheumatoid arthritis	0.000236	0.00592	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PRKCQ—rheumatoid arthritis	0.000233	0.00586	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNFSF13—rheumatoid arthritis	0.000232	0.00583	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.000232	0.00582	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—CXCL8—rheumatoid arthritis	0.00023	0.00577	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—ALOX5—rheumatoid arthritis	0.000223	0.00559	CbGpPWpGaD
Lornoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—rheumatoid arthritis	0.000214	0.00538	CbGpPWpGaD
Lornoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—rheumatoid arthritis	0.000207	0.0052	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—ETS1—rheumatoid arthritis	0.000206	0.00517	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—MPO—rheumatoid arthritis	0.000205	0.00514	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—TNF—rheumatoid arthritis	0.000202	0.00506	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—rheumatoid arthritis	0.000198	0.00497	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—MPO—rheumatoid arthritis	0.000197	0.00495	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—rheumatoid arthritis	0.000194	0.00487	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—rheumatoid arthritis	0.000192	0.00482	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—rheumatoid arthritis	0.000189	0.00474	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SAA1—rheumatoid arthritis	0.000187	0.0047	CbGpPWpGaD
Lornoxicam—PTGS2—S1P1 pathway—VEGFA—rheumatoid arthritis	0.000187	0.00469	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—GATA3—rheumatoid arthritis	0.000185	0.00464	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—COL2A1—rheumatoid arthritis	0.000182	0.00458	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—rheumatoid arthritis	0.00018	0.00453	CbGpPWpGaD
Lornoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.00018	0.00451	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—rheumatoid arthritis	0.000176	0.00443	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—C5—rheumatoid arthritis	0.000176	0.00442	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CDK6—rheumatoid arthritis	0.000175	0.0044	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—rheumatoid arthritis	0.000173	0.00434	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.00017	0.00428	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—CAT—rheumatoid arthritis	0.000165	0.00413	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—IL6—rheumatoid arthritis	0.000163	0.00409	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—TNF—rheumatoid arthritis	0.00016	0.00402	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—FCGR2A—rheumatoid arthritis	0.000158	0.00397	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—rheumatoid arthritis	0.000157	0.00393	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SOD2—rheumatoid arthritis	0.000156	0.00392	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CXCL2—rheumatoid arthritis	0.000151	0.0038	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	0.000138	0.00346	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—MTHFR—rheumatoid arthritis	0.000137	0.00345	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000135	0.00339	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—CRP—rheumatoid arthritis	0.000131	0.00328	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—CAT—rheumatoid arthritis	0.000131	0.00328	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—IL6—rheumatoid arthritis	0.000129	0.00324	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SOD2—rheumatoid arthritis	0.000124	0.00311	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000121	0.00304	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—ICAM1—rheumatoid arthritis	0.00012	0.00302	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—rheumatoid arthritis	0.000114	0.00286	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CXCL10—rheumatoid arthritis	0.000114	0.00286	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000114	0.00285	CbGpPWpGaD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—rheumatoid arthritis	0.00011	0.00276	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—MTHFR—rheumatoid arthritis	0.000109	0.00274	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	0.000107	0.0027	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—rheumatoid arthritis	0.000106	0.00266	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—CRP—rheumatoid arthritis	0.000104	0.00261	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	0.000101	0.00255	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—rheumatoid arthritis	0.000101	0.00254	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	0.0001	0.00252	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	0.0001	0.00252	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—ALB—rheumatoid arthritis	0.0001	0.00252	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL1A—rheumatoid arthritis	9.81e-05	0.00246	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—ICAM1—rheumatoid arthritis	9.53e-05	0.00239	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL4—rheumatoid arthritis	9.49e-05	0.00238	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	9.33e-05	0.00234	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	9.2e-05	0.00231	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	9.14e-05	0.0023	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	9.01e-05	0.00226	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	8.95e-05	0.00225	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—rheumatoid arthritis	8.76e-05	0.0022	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	8.66e-05	0.00217	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—rheumatoid arthritis	8.65e-05	0.00217	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	8.53e-05	0.00214	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	8.18e-05	0.00205	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	8.15e-05	0.00205	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—LEP—rheumatoid arthritis	8.03e-05	0.00202	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	7.96e-05	0.002	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	7.96e-05	0.002	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—ALB—rheumatoid arthritis	7.95e-05	0.002	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	7.89e-05	0.00198	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TLR4—rheumatoid arthritis	7.86e-05	0.00198	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	7.85e-05	0.00197	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	7.84e-05	0.00197	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	7.6e-05	0.00191	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—FADS2—rheumatoid arthritis	7.58e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—ICAM1—rheumatoid arthritis	7.54e-05	0.00189	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—NOS2—rheumatoid arthritis	7.48e-05	0.00188	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	7.4e-05	0.00186	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—rheumatoid arthritis	7.38e-05	0.00185	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CD4—rheumatoid arthritis	7.27e-05	0.00183	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	7.25e-05	0.00182	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	7.24e-05	0.00182	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CCL2—rheumatoid arthritis	6.75e-05	0.00169	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	6.49e-05	0.00163	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	6.47e-05	0.00163	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—POMC—rheumatoid arthritis	6.42e-05	0.00161	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	6.36e-05	0.0016	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	6.3e-05	0.00158	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	6.17e-05	0.00155	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	6.04e-05	0.00152	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—FADS2—rheumatoid arthritis	6.02e-05	0.00151	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	5.97e-05	0.0015	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	5.95e-05	0.00149	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—TNF—rheumatoid arthritis	5.91e-05	0.00149	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	5.74e-05	0.00144	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	5.33e-05	0.00134	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	5.27e-05	0.00132	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	5.27e-05	0.00132	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SYVN1—rheumatoid arthritis	5.19e-05	0.0013	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	5.12e-05	0.00129	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	5.1e-05	0.00128	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PLD4—rheumatoid arthritis	5.06e-05	0.00127	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5e-05	0.00126	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.9e-05	0.00123	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ACAN—rheumatoid arthritis	4.88e-05	0.00123	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	4.82e-05	0.00121	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL6—rheumatoid arthritis	4.77e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	4.69e-05	0.00118	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ACAN—rheumatoid arthritis	4.63e-05	0.00116	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC25A12—rheumatoid arthritis	4.59e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GC—rheumatoid arthritis	4.47e-05	0.00112	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGES—rheumatoid arthritis	4.47e-05	0.00112	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC25A12—rheumatoid arthritis	4.35e-05	0.00109	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	4.3e-05	0.00108	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PLB1—rheumatoid arthritis	4.15e-05	0.00104	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PLD4—rheumatoid arthritis	4.01e-05	0.00101	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	3.98e-05	0.001	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	3.98e-05	0.000999	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PLB1—rheumatoid arthritis	3.94e-05	0.000989	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACAN—rheumatoid arthritis	3.88e-05	0.000974	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	3.79e-05	0.000952	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	3.71e-05	0.000933	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	3.65e-05	0.000916	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MED1—rheumatoid arthritis	3.64e-05	0.000915	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RBPJ—rheumatoid arthritis	3.63e-05	0.000913	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTGES—rheumatoid arthritis	3.55e-05	0.000891	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GC—rheumatoid arthritis	3.55e-05	0.000891	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ACP5—rheumatoid arthritis	3.39e-05	0.00085	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—B3GNT2—rheumatoid arthritis	3.39e-05	0.00085	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	3.38e-05	0.000848	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	3.31e-05	0.000832	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PLB1—rheumatoid arthritis	3.3e-05	0.000828	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	3.27e-05	0.000822	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	3.25e-05	0.000816	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—B3GNT2—rheumatoid arthritis	3.21e-05	0.000806	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ACP5—rheumatoid arthritis	3.21e-05	0.000806	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	3.19e-05	0.000802	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BGN—rheumatoid arthritis	3.05e-05	0.000766	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	3e-05	0.000753	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	2.95e-05	0.00074	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MED1—rheumatoid arthritis	2.89e-05	0.000726	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BGN—rheumatoid arthritis	2.89e-05	0.000726	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TLE3—rheumatoid arthritis	2.89e-05	0.000726	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	2.81e-05	0.000705	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	2.7e-05	0.000679	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	2.69e-05	0.000675	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACP5—rheumatoid arthritis	2.69e-05	0.000675	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	2.66e-05	0.000668	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC11A1—rheumatoid arthritis	2.64e-05	0.000662	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NFATC1—rheumatoid arthritis	2.62e-05	0.000657	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	2.57e-05	0.000645	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	2.53e-05	0.000634	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.47e-05	0.00062	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NCF2—rheumatoid arthritis	2.43e-05	0.000611	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BGN—rheumatoid arthritis	2.42e-05	0.000608	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	2.41e-05	0.000606	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	2.35e-05	0.00059	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GC—rheumatoid arthritis	2.35e-05	0.00059	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ENO1—rheumatoid arthritis	2.29e-05	0.000574	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.25e-05	0.000565	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SAA1—rheumatoid arthritis	2.24e-05	0.000562	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	2.23e-05	0.000559	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	2.23e-05	0.000559	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NCF1—rheumatoid arthritis	2.19e-05	0.00055	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	2.18e-05	0.000548	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ENO1—rheumatoid arthritis	2.17e-05	0.000545	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD28—rheumatoid arthritis	2.11e-05	0.000529	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—UBE2D1—rheumatoid arthritis	1.98e-05	0.000498	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.97e-05	0.000494	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.96e-05	0.000492	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ADRBK1—rheumatoid arthritis	1.92e-05	0.000483	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MED1—rheumatoid arthritis	1.91e-05	0.000481	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ENO1—rheumatoid arthritis	1.82e-05	0.000456	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.79e-05	0.000449	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	1.78e-05	0.000447	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	1.78e-05	0.000447	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRKCQ—rheumatoid arthritis	1.77e-05	0.000446	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT1—rheumatoid arthritis	1.74e-05	0.000438	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAT—rheumatoid arthritis	1.65e-05	0.000413	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BGN—rheumatoid arthritis	1.6e-05	0.000403	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	1.47e-05	0.00037	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	1.37e-05	0.000345	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CCR5—rheumatoid arthritis	1.33e-05	0.000335	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAT—rheumatoid arthritis	1.31e-05	0.000328	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—rheumatoid arthritis	1.3e-05	0.000327	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HLA-A—rheumatoid arthritis	1.3e-05	0.000326	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.3e-05	0.000326	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	1.2e-05	0.000302	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.18e-05	0.000297	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6ST—rheumatoid arthritis	1.14e-05	0.000286	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS2—rheumatoid arthritis	1.13e-05	0.000284	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—POMC—rheumatoid arthritis	1.1e-05	0.000276	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD80—rheumatoid arthritis	1.1e-05	0.000275	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	1.09e-05	0.000274	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.03e-05	0.00026	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6R—rheumatoid arthritis	1.02e-05	0.000255	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALB—rheumatoid arthritis	1e-05	0.000252	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NOS3—rheumatoid arthritis	9.58e-06	0.000241	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TYK2—rheumatoid arthritis	9.25e-06	0.000232	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS3—rheumatoid arthritis	9.08e-06	0.000228	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	8.76e-06	0.00022	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—POMC—rheumatoid arthritis	8.72e-06	0.000219	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAT—rheumatoid arthritis	8.65e-06	0.000217	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD4—rheumatoid arthritis	8.37e-06	0.00021	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALB—rheumatoid arthritis	7.95e-06	0.0002	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NOS3—rheumatoid arthritis	7.61e-06	0.000191	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	7.22e-06	0.000181	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFB1—rheumatoid arthritis	6.01e-06	0.000151	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—POMC—rheumatoid arthritis	5.78e-06	0.000145	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALB—rheumatoid arthritis	5.27e-06	0.000132	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	5.04e-06	0.000127	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	4.61e-06	0.000116	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—rheumatoid arthritis	4.53e-06	0.000114	CbGpPWpGaD
